Compare NRP & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRP | WGS |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1300 |
| Industry | Coal Mining | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2002 | N/A |
| Metric | NRP | WGS |
|---|---|---|
| Price | $99.11 | $67.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $120.71 |
| AVG Volume (30 Days) | 37.1K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $216,119,000.00 | N/A |
| Revenue This Year | N/A | $29.98 |
| Revenue Next Year | N/A | $25.92 |
| P/E Ratio | ★ $11.28 | $1,251.58 |
| Revenue Growth | ★ 54.66 | N/A |
| 52 Week Low | $96.39 | $32.21 |
| 52 Week High | $128.60 | $170.87 |
| Indicator | NRP | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 37.47 | 60.20 |
| Support Level | N/A | $55.76 |
| Resistance Level | $108.19 | $73.46 |
| Average True Range (ATR) | 2.85 | 4.44 |
| MACD | 0.03 | 0.99 |
| Stochastic Oscillator | 28.30 | 69.99 |
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. The majority of the revenue is generated from the Mineral Rights segment. Geographically, the company's business activity of the group functions through the United States.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.